Gastric cancer - PubMed (original) (raw)
Gastric cancer
Henk H Hartgrink et al. Lancet. 2009.
Abstract
Gastric cancer is the second most frequent cause of cancer death worldwide, although much geographical variation in incidence exists. Prevention and personalised treatment are regarded as the best options to reduce gastric cancer mortality rates. Prevention strategies should be based on specific risk profiles, including Helicobacter pylori genotype, host gene polymorphisms, presence of precursor lesions, and environmental factors. Although adequate surgery remains the cornerstone of gastric cancer treatment, this single modality treatment seems to have reached its maximum achievable effect for local control and survival. Minimally invasive techniques can be used for treatment of early gastric cancers. Achievement of locoregional control for advanced disease remains very difficult. Extended resections that are standard practice in some Asian countries have not been shown to be as effective in other developed countries. We present an update of the incidence, causes, pathology, and treatment of gastric cancer, consisting of surgery, new strategies with neoadjuvant and adjuvant chemotherapy or radiotherapy, or both, novel treatment strategies using gene signatures, and the effect of caseload on patient outcomes.
Conflict of interest statement
Conflicts of interest
We declare that we have no conflicts of interest.
Figures
Figure 1
Correa sequence precursor gastric lesions Sequence shows increasing risk for development of intestinal-type gastric carcinoma. (A) Normal mucosa. (B) Chronic gastritis. (C) Mucosal atrophy. (D) Intestinal metaplasia. (E) Dysplasia. (F) Intestinal-type carcinoma.
Figure 2
Survival in patients with positive or negative resection lines Data adapted from Songun and co-workers.
Figure 3
Lymph-node stations surrounding stomach 1=right cardial nodes. 2=left cardial nodes. 3=nodes along lesser curvature. 4 s and 4 d=nodes along greater curvature. 5=suprapyloric nodes. 6=infrapyloric nodes. 7=nodes along left gastric artery. 8=nodes along common hepatic artery. 9=nodes around celiac axis. 10=nodes at splenic hilus. 11=nodes along splenic artery. 12=nodes in hepatoduodenal ligament. 13=nodes at posterior aspect of pancreas head. 14=nodes at root of mesenterium. 15=nodes in mesocolon of transverse colon. 16=para-aortic nodes.
Figure 4
Overall survival based on Maruyama Index (MI) analysis Overall survival for 648 patients with MI<5 and MI>5 status. Patients from Dutch D1–D2 trial cases (p<0·0001).
Figure 5
Typical intensity modulated radiotherapy (IMRT) beam setup IMRT beam setup for postoperative gastric cancer treatment. Blue=liver. Red=clinical target volume. Yellow=right kidney. Green=left kidney.
Figure 6
Radiotherapy and IMRT planning for gastric cancer IMRT=intensity modulated radiotherapy. Red line=clinical target volume. Green line=right kidney. Purple line=left kidney. Improved sparing of kidneys and optimum coverage of clinical target volume is possible with present radiotherapy techniques. (A) Result of a two-dimensional anterior-posterior posterior-anterior (APPA) radiotherapy plan. (B) Result of an IMRT plan.
Comment in
- Gastric cancer.
Fujita T. Fujita T. Lancet. 2009 Nov 7;374(9701):1593-4; author reply 1594-5. doi: 10.1016/S0140-6736(09)61946-2. Lancet. 2009. PMID: 19897122 No abstract available. - Gastric cancer.
Fernández-Fernández FJ, Sesma P. Fernández-Fernández FJ, et al. Lancet. 2009 Nov 7;374(9701):1594; author reply 1594-5. doi: 10.1016/S0140-6736(09)61947-4. Lancet. 2009. PMID: 19897123 No abstract available.
Similar articles
- [Looking back 2018--focused on gastric cancer].
Li Z, Gao X. Li Z, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Jan 25;22(1):1-8. Zhonghua Wei Chang Wai Ke Za Zhi. 2019. PMID: 30703786 Chinese. - Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies.
Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Machlowska J, et al. Int J Mol Sci. 2020 Jun 4;21(11):4012. doi: 10.3390/ijms21114012. Int J Mol Sci. 2020. PMID: 32512697 Free PMC article. Review. - Gastric Cancer Working Group report.
Sasako M, Inoue M, Lin JT, Khor C, Yang HK, Ohtsu A. Sasako M, et al. Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i28-37. doi: 10.1093/jjco/hyq124. Jpn J Clin Oncol. 2010. PMID: 20870917 - Can the incidence of gastric cancer be reduced in the new century?
Hu Y, Fang JY, Xiao SD. Hu Y, et al. J Dig Dis. 2013 Jan;14(1):11-5. doi: 10.1111/j.1751-2980.2012.00647.x. J Dig Dis. 2013. PMID: 23134264 Review. - Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy.
Donida BM, Tomasello G, Ghidini M, Buffoli F, Grassi M, Liguigli W, Maglietta G, Pergola L, Ratti M, Sabadini G, Toppo L, Ungari M, Passalacqua R. Donida BM, et al. BMC Cancer. 2019 Mar 8;19(1):212. doi: 10.1186/s12885-019-5366-1. BMC Cancer. 2019. PMID: 30849945 Free PMC article.
Cited by
- Roles of Ion and Water Channels in the Cell Death and Survival of Upper Gastrointestinal Tract Cancers.
Shiozaki A, Marunaka Y, Otsuji E. Shiozaki A, et al. Front Cell Dev Biol. 2021 Mar 11;9:616933. doi: 10.3389/fcell.2021.616933. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 33777930 Free PMC article. Review. - Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer.
Kim SJ, Lee HW, Baek JH, Cho YH, Kang HG, Jeong JS, Song J, Park HS, Chun KH. Kim SJ, et al. Oncogene. 2016 Jan 14;35(2):251-60. doi: 10.1038/onc.2015.80. Epub 2015 Mar 30. Oncogene. 2016. PMID: 25823029 - Oxidative stress and autophagy-mediated immune patterns and tumor microenvironment infiltration characterization in gastric cancer.
Liu J, Zhang B, Zhang Y, Zhao H, Chen X, Zhong L, Shang D. Liu J, et al. Aging (Albany NY). 2023 Nov 9;15(21):12513-12536. doi: 10.18632/aging.205194. Epub 2023 Nov 9. Aging (Albany NY). 2023. PMID: 37950729 Free PMC article. - Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy.
Lin C, Liu H, Zhang H, He H, Li H, Shen Z, Qin J, Qin X, Xu J, Sun Y. Lin C, et al. Oncotarget. 2016 Aug 2;7(31):49281-49288. doi: 10.18632/oncotarget.10297. Oncotarget. 2016. PMID: 27351230 Free PMC article. - Effect of three common IL-17 single nucleotide polymorphisms on the risk of developing gastric cancer.
Gao YW, Xu M, Xu Y, Li D, Zhou S. Gao YW, et al. Oncol Lett. 2015 Mar;9(3):1398-1402. doi: 10.3892/ol.2014.2827. Epub 2014 Dec 23. Oncol Lett. 2015. PMID: 25663919 Free PMC article.
References
- Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006;24:2137–50. - PubMed
- Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer. 2007;10:75–83. - PubMed
- Bae JM, Lee EJ, Guyatt G. Citrus fruit intake and stomach cancer risk: a quantitative systematic review. Gastric Cancer. 2008;11:23–32. - PubMed
- Hanley AJ, Choi BC, Holowaty EJ. Cancer mortality among Chinese migrants: a review. Int J Epidemiol. 1995;24:255–65. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical